Sickle Cell Disease
Sickle Cell Disease
Advertisement
Patrick DalySickle Cell Disease | April 22, 2024
Dr. Vadivelan shared her study on pituitary and pancreatic iron deposition in patients with SCD at the 2024 ASPHO Conference.
View More
Patrick DalySickle Cell Disease | April 19, 2024
Stuart Orkin, MD, has been named as one of Time’s 100 Most Influential People of 2024 for his work in hemoglobin research.
Melissa BadamoSickle Cell Disease | April 18, 2024
The study compared health care resource use and costs of pediatric patients with SCD compared with matched controls.
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 12, 2024
Dr. Ansong-Ansongton shared what National Minority Health Month and Celebrate Diversity Month mean to him at ASPHO 2024.
Yaw Ansong-Ansongton, MDSickle Cell Disease | April 9, 2024
Dr. Ansong-Ansongton described data on the impact of abnormal mitochondrial retention and cold in red blood cells in SCD.
Zaina Inam, MDSickle Cell Disease | April 5, 2024
The study evaluated transplant outcomes in pediatric patients with SCD who had a history of red blood cell alloimmunization.
Patrick DalySickle Cell Disease | April 4, 2024
A standardized, local TCD supported by central quality review was implemented effectively in resource-constrained settings.
Melissa BadamoSickle Cell Disease | March 25, 2024
The two-year event-free survival was estimated to be 82.6%, and the two-year overall survival was 94.1%.
Patrick DalySickle Cell Disease | March 8, 2024
A new bill seeks to add a SCD health home model to state Medicaid programs to improve access and quality of treatment.
Patrick DalySickle Cell Disease | March 9, 2024
A myeloablative conditioning regimen containing thiotepa had promising efficacy and safety in patients with severe SCD.
Zahra Pakbaz, MDSickle Cell Disease | February 27, 2024
Dr. Pakbaz describes some of the difficulties faced by patients with SCD as they switch from pediatric to adult programs.
Patrick DalySickle Cell Disease | February 26, 2024
Reduction of hemolysis significantly predicted postinfusion transduction efficacy in patients with SCD treated with lovo-cel.
Melissa BadamoSickle Cell Disease | February 22, 2024
Exa-cel eliminated RBC transfusions in patients with transfusion-dependent β-thalassemia.
Melissa BadamoSickle Cell Disease | February 21, 2024
Hydroxyurea therapy reduced blood transfusion by 75% among pediatric patients in sub-Saharan Africa with sickle cell anemia.
Patrick DalySickle Cell Disease | February 20, 2024
The European Commission has approved the Conditional Marketing Authorization for exagamglogene autotemcel.
Patrick DalySickle Cell Disease | February 13, 2024
Drs. Grant, Sutin, and Lin discuss their pilot study investigating cerebral hemodynamics in infants with sickle cell disease.
John Strouse, MD, PhDSickle Cell Disease | March 19, 2024
Dr. Pakbaz and Dr. Strouse discuss their experiences practicing classical hematology and where the speciality is heading.
Patrick DalySickle Cell Disease | February 8, 2024
Dr. Pakbaz, from the University of California Irvine, shared data on the value of a dedicated classical hematology clinic.
Patrick DalySickle Cell Disease | January 29, 2024
Most patients with SCD with gallstones reached an advanced stage of gallstones by the time they underwent a cholecystectomy.
Patrick DalySickle Cell Disease | February 8, 2024
Therapy with isoquercetin induced positive reductions in several biomarkers for thromboinflammation in sickle cell disease.
Advertisement
Advertisement
Advertisement
Latest News

April 23, 2024